drugset / Trial / NCT00904423

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

NCT00904423

NaSingle-groupOpen-labelTreatment

Summary

Aromatase inhibitors are potent suppressors of breast cancer growth, but side effects include bone loss, fractures, arthralgias and myalgias. We hypothesize vitamin D administration might be beneficial in treating these symptoms and to protect bone.

Timeline

Start
2009-04
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 2400 mg Oral